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INTRODUCTION 
¾ Thyroid gland was first documented by Italians of the renaissance 
period. 
¾ The term Thyroid (Greek – Thyreoeides, shield shaped) is 
attributed to Thomas warton.  
¾ Goitre is derived from the Latin word Gutter which means 
“Throat.” 
¾ The most notable thyroid surgeons were Emil Theodar Kocher 
(1841 – 1917) and Theodor Billroth (1829-1894) 
¾ Emil Theodor Kocher of Berne is regarded by many as “Father of 
Thyroid Surgery”. 
¾ In 1909, Kocher received the nobel prize for Medicine in 
recognition for his works on physiology, pathology & surgery of 
thyroid gland. 
¾ Bernard Courtois discovered iodine in the ash of burnt sea weed. 
The first accounts of thyroid surgery dates back to Roger frugardi 
in 1170. 
¾ Thyrotoxicosis is a syndrome  which is caused by excessive 
secretion of Thyroid hormones. 
¾ Hyperthyroidism is hyperfunctioning of thyroid with elevated 
levels of thyroid hormones. 
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AIM OF STUDY 
1. Review the data regarding prevalence of thyrotoxicosis & its 
association with standard variables. 
2. Discuss the various clinical presentations of thyrotoxicosis. 
3. Discussion of etiopathogenesis in Thyrotoxicosis 
4. Discussion of various treatment Modalities 
5. Evaluate a cost effective treatment for a country like ours. 
6. Discuss the complication of treatment and follow up. 
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REVIEW OF LITERATURE 
ANATOMY 
 The Thyroid gland occupies an important position in the middleof 
the visceral compartment of neck, lying astride the trachea just above the 
thoracic inlet. It normally weighs about 15 – 20gm. 
 The gland consists of two symmetrical lobes, united by an isthmus 
of thyroid infront of 2nd, 3rd, and 4th tracheal rings. The extent of Thyroid 
gland is from Thyroid Cartilage to the 5th or 6th tracheal ring or from C3 -
T1. 
 The lobes are approximately 4cm long, 2cm wide, 20-40mm thick, 
with the isthmus 2-6mm thick. Each lobe is pear shaped, consisting of a 
narrow upper pole and broader lower pole. The thyroid gland is covered 
by fascia and strap muscles and more laterally, it is tucked under the 
diverging anterior borders of the sternocleidomastoid muscles and 
adjacent to the lobes on the medial side, is the carotid sheath. 
Pyramidal lobe: 
 It is present in 80% of individuals. Usually to the left of midline 
extending upwards from the isthmus along the anterior surface of the 
thyroid cartilage. It is a remnant of thyro-glossal duct. 
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 The gland moves upwards on deglutition because of fascial 
attachment. The normal gland is impalpable though it can be palpated in 
thin individuals. 
The gland moves upwards on deglutition because: 
• Thyroid is ensheathed in the pretracheal fascia  
• Pretracheal fascia is condensed posteriorly to form ligament of 
Berry. 
• Thyroid cartilage is attached to the hyoid bone through the 
thyrohyoid membrane.  
Fascial Coverings: 
 The strap muscles are ensheathed by the investing layer of deep 
cervical fascia. These muscles are applied to the anterior surface of the 
gland but separated by a loose condensation of fascia derived from the 
Pre tracheal  fascia. This false capsule covers the gland which is enclosed 
by its true capsule with its rich blood supply. 
 The pre-tracheal fascia is attached above to the thyroid cartilage 
and cricoid cartilage and this suspension of thyroid from the larynx 
accounts for its movements on deglutition. 
 During surgery, the investing layer of deep cervical fascia is 
opened in the Midline vertically which is relatively avascular. The space 
between the gland and strap muscles is entered by retracting the strap 
musscle. 
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 The strap muscles are supplied from the cervical roots 1,2,3 via 
ansa cervicalis. These enter the muscles at its lateral border and on the 
deeper surface and the muscles can be divided transversely to facilitate  
access to the gland, provided they are resutured, there does not appear to 
be any functional impairment. 
Blood Supply 
Arterial supply 
 Artery     Origin 
Superior thyroid Artery    External Carotid Artery 
Inferior Thyroid Artery    Thyro-cervical trunk from 
Ist  
part of subclavian artery. 
Thyroidea Ima Artery    Arch of aorta 
(or) Innominate Artery 
 The Superior thyroid artery descends from its origin and runs to the 
superior pole and as it reaches the gland it divides into Anterior and 
posterior branches. 
 The Inferior thyroid Artery passes behind the carotid sheath and 
runs transversely across the space between the thyroid and carotid sheath 
to enter the deep surface of the gland as separate branches. The recurrent 
laryngeal nerve usually lies posterior to these branches or some times in 
between  or anterior to them. 
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Venous drainage 
 A rich venous plexus forms underneath the capsule and drains 
corresponding as follows. 
Vein        Drain 
Superior thyroid vein     Internal Jugular vein 
Middle Thyroid vein     IJV 
Inferior thyroid vein     Brachio-cephalic vein 
 The middle thyroid vein runs a short course, passes from middle of  
the gland and directly enter the IJV. 
 From the isthmus and lower pole  the inferior thyroid vein forms a 
plexus that lies in the pre-tracheal fascia and drains into the brachio – 
cephalic vein. 
Lymphatic drainage: 
 The lymphatic drainage of the thyroid is principally to the Internal 
Jugular nodes. The superior pole and the medial isthmus drain to the 
superior group and the Inferior drain the lower gland and empty into 
pretracheal and Para tracheal nodes. 
Nerve Supply: 
 Sympathetic  - Middle and Inferior cervical sympathetic 
ganglia 
 Para Sympathetic - Laryngeal branch of vagus  
 Superior laryngeal Nerve    External  
Internal   
Recurrent laryngeal Nerve. 
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 The sympathetic nerves travel along the blood vessels to the 
thyroid and are vasomotor in action. The thyroid gland’s relation to the 
Recurrent Laryngeal Nerve and External laryngeal nerve is of major 
significance. Identification of these nerves rather than avoiding should be 
a standard practice for the surgeon. 
 The recurrent laryugeal nerve supplies the intrinsic muscles of 
larynx except the cricothyroid which is supplied by the Ext. laryngeal 
nerve cricothyroid is a tensor of vocal cord and affects the pitch of voice. 
Recurrent Laryugeal Nerve: 
Right:  
Recurrent laryngeal nerve originates from the vagus and it crosses 
the Ist part sub clavian Artery. The Nerve then loops the subclavian artery 
and ascends slight obliquely to enter the larynx at the level of cricoid 
cartilage and posterior to the cricothyroid muscle. 
Left:  
The Nerve originates from the vagus as it crosses the aortic arch 
and loops posteriorly around the ligamentum arteriosus before it ascends 
medially in the tracheo-oesophageal groove to enter the larynx. 
Nerve in Tracheo-Oesophageal groove 
  Right  -  64% 
  Left   -  77% 
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Nerve in relation to Inferior thyroid artery 
 Posterior to artery  - Right -  53% 
       Left  -  69% 
 In others, the nerve is either anterior or in between the branches. 
The most meticulous step during thyroid surgery is during the dissection 
where RLN passes through the Berry’s Ligament. It is here the nerve is in 
close proximity to the thyroid gland, tethered down by the ligament and it 
is here the nerve is most commonly injured.  
Non-Recurrent RLN: 
• Exclusively on Right side 
• 1% of Individuals 
• Associated with anomaly of subclavian Artery Right side 
• Nerve runs directly to the larynx after its origin from the vagus. 
External Laryngeal Nerve: 
 The nerve runs on the lateral surface of the Inferior constrictor 
muscle to innervate the crico-thyroid and lies in close proximity  to the 
superior pole vessels. 
 Nerve supplies the cricothyroid  muscle which tensors of  vocal 
cord which affects the pitch of the voice. In 80% of individuals the nerve 
can be found over the cricothyroid muscle.  
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Histology of thyroid gland: 
 Microscopically the gland is divided into lobules that contain 20-40 
follicles. Follicles are spherical and average 30 mμ  in size. Follicle is 
lined by cuboidal epithelium and contains a central core of colloid 
secreted from the epithelial cells. 
 When the gland activity is more as in the case of Hyperthyroidism, 
the follicular epithelium is tall columnar and the colloid is reduced. 
 Sparsely intermingled between the follicular cells and also within 
the inter follicular spaces are the parafollicular or ‘C’ cells which secrete 
calcitonin. 
 The ‘C’ cells are mostly concentrated in the superior pole, 
reflecting their origin as neuro ectodermal cells derived from the ultimo-
branchial bodies and are a part of APUD series described by pearse. 
Development of thyroid: 
Embryology of thyroid: 
 The thyroid develops as an endodermal tubular structure from the 
posterior aspect of fetal tongue and grows downwards in front of the 
developing hyoid and larynx, bifurcating and fusing with growth 
elements. From 4th branchial pouch. The stem of the down growth forms 
the Thyroglossal duct whose upper end remains as foramen caecum of the 
tongue, the lower end forms the pyramidal lobe. Thyroglossal duct 
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usually atrophies but many remain in whole or in part and produce 
abnormalities. 
 It is Joined laterally by a pair of components originating from the 
ultimo-branchial bodies of the 4th and 5th pharyngeal pouches These 
lateral components supply the ‘C’ cells of thyroid which secrete 
calcitonin. 
 The superior parathyroid develops from 4th pharyngeal pouch and it 
is in close relationship to superior aspect of thyroid. 
 The Inferior parathyroids develop from 3rd pharyngeal pouch and is 
developmentally related to thymus. 
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PHYSIOLOGY 
Iodine Metabolism  
 The average daily requirement of iodine is 0.1mg. Iodine in the 
stomach and jejunum is converted to Iodide and is absorbed. It is actively 
transported to thyroid by an ATP dependent process. The Normal serum 
to thyroid iodine ratio is about 1:5. But can be as high as 1:500. 
 Thyroid hormones T3 and T4 are bound to Thyroglobulin within 
the colloid. 
Synthesis is as follows: 
• Trapping of organic iodide 
• Oxidation of Iodide to iodine 
• Binding of iodine with tyrosine to form iodothyronine 
• Coupling of Mono-iodotyrosine (MIT) and di-iodotyrosine (DIT) 
to form T3, T4 and free T3  
All the above steps in thyroid synthesis is accelerated by TSH, 
acting through a specific membrane receptor via the cyclic AMP second 
messenger system. 
The coupling and oxidation of iodide are catalyzed by peroxidase  
enzyme which is inhibited by propylthiouracil and carbimazole.  
The hormones so synthesized are stored in colloid within the 
thyroglobulin. When the hormones are required the complex is 
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reabsorbed into the epithelium by endocytosis and broken down by the 
lysosomes. This results in the formation of T4, T3, RT3, MIT, DIT. 
The MIT and DIT are denominated and iodine is reused. The T3 
and T4 enter the circulation and transported bound to thyroxine binding 
globulin (TBG) Thyroxine binding pre albumin (TBPA) and albumin. 
99.98% of thyroid hormones are bound to protein and only 0.02% 
is free & active physiological form, rT3 is biologically inert. The 
circulating level of T4 to T3 is 10:1 to 20:1 T3 is more potent, less lightly 
bound to protein, 3-4 times more active than T4. About 75% of T3 is 
produced from peripheral conversion of T4 to T3 which is inhibited by β-
Blockers. 
Hypothalamus – Pituitary – Thyroid Axis: 
Synthesis and liberation of thyroid hormone is controlled by TSH. 
(Thyrotropin) TSH is secreted by basophil cells of Anterior pituitary. The 
TSH is in turn controlled by Thyrotropin releasing hormone (TRH) 
secreted by Hypothalamus. 
Molecular Basis of thyroid hormone action: 
The thyroid hormones are transported across the plasma membrane 
of the tissues by ATP dependent transport system. 
 Uptake by the tissue is rate limited by the amount of free hormone 
available at the tissue level. 
At the cellular level T3 is the active hormone and its activity is 
mediated through T3 receptors located in the cell nucleus. 
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OUTLINE OF THYROTOXICOSIS 
Syndrome that results when excessive levels of thyroid hormones 
are secreted into circulation. The term Thyrotoxicosis is retained because 
symptoms due to raised level of hormone is not responsible for all 
manifestations of the disease. 
Classification 
I. Based on Etilogy: 
A. Primary alteration within the thyroid 
• Grave’s disease 
• Toxic Multi nodular goitre 
• Toxic Adenoma 
B. CNS – Disorders – increased TSH Secretion 
II. Based on Hormone Secretion 
With increased thyroid hormone secretion 
• Grave’s disease – Primary thyrotoxicosis  
• Toxic nodular goitre 
• Toxic Thyroid adenoma 
• Jod Basedow Hyperthyroidism 
Without increased thyroid Hormone Secretion: 
• Subacute thyroiditis 
• Factitious Hyper thyroidism 
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• Functioning Metastatic Ca thyroid 
• Struma ovari (ovarian teratoma containing thyroid) 
• Molar pregancy – increased β – HCG 
Etio – Pathogenesis: 
Grave’s disease – (Diffuse toxic goitre) 
Originally described by caleb pary – welsch physician 1825. 
Named after Robert graves, Ireland 1835. 
• It is the most common form of Thyrotoxicosis 
• Affects young adults (20-40 yrs) 
• 6 times more common in females. 
Extra thyroidal Manifestations: 
Ophthalmopathy, pretibial Myxoedema, vitiligo, Thyroid 
Acropachy. 
Etiology: 
It is an autoimmune disorder. The disease was originally thought to 
be due to LATS. (Long acting thyroid stimulating antibody) described by 
Adams and  parves in 1956. 
It is recently demonstrated that the disease is due to wide range  of 
antibodies termed as TRAb. (Thyroid receptor Antibodies). Thyroid 
stimulating antibodies (or) Ig are directed at TSH receptors on – follicular 
cells. 
TSH (or) TBIA – TSH binding inhibiting Ig or Antibodies. All 
these Ab are grouped as TRAb. 
What initiates the Graves and Antibodies production is unclear. 
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Various theories: 
1. Defect in the T-Suppressor cells 
2. Immune response is launched to altered antigen on the follicular 
cell surface 
3. Genetic factors – Twins have increased chance probably due to 
increased frequency of association with HLA B8 and DR3 in 
caucasians. HLA – BW 35 in Japanese. 
Family H/o autoimmune disease, Graves disease, Hashimoto’s 
disease may be associated.  
PATHOLOGY 
Macroscopic Appearance 
 Gland is diffuse, symmetrical, smoothly enlarged with increased 
vascularity. 
Microscopic appearance: 
 Cells are hyperplastic with columnar epithelium, papillary 
projection and mitosis and with aggregates of lymphoid tissue, colloid is 
reduced. 
Many follicles are empty. Some contain vacuolated colloid with 
the characteristic scalloped pattern adjacent to thyrocytes.  
Toxic Multi nodular goitre: 
• Secondary Thyrotoxicosis 
• Toxic nodular goitre – plummer’s disease 
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• Long standing Multi nodular goitre becomes hyperactive over long 
period. 
• Middle or elderly aged females 
• Hyperthyroidism is relatively mild 
• Not associated with extra thyroidal manifestation 
• Gland is nodular and eye signs less common. 
 In many cases it is the inter nodular tissue that is active and 
nodules are inactive. In some cases the nodules are active, and here the 
toxicosis is due to autonomous nodules as in toxic adenoma. 
Solitary Toxic nodule 
Toxic Adenoma 
 One or more nodules trapping and organifying more iodine and  
secreting more hormone, thereby producing hyperthyroidism 
independently of TSH control. 
It is autonomous – not due to TRAb TSH secretion is suppressed 
by high levels of circulating hormones. Normal thyroid tissue 
surrounding the nodule is suppressed and inactive. Adenoma is usually 
>3cm in diameter pathogenesis of Dermopathy and ophthalmopathy is 
immune mediated but not due to TRAb, less well understood. 
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Pathogenesis of Graves ophthalmopathy: 
 It is an autoimmune disorder Immunologically mediated, but not 
due to TRAb. Orbital muscles and fibroblasts share a common antigen 
with thyrocytes, TSH receptor. 
 Fibroblasts proliferation in orbit leading to accumulation of 
hydrophilic glycosaminoglycans in the retro orbital tissues which leads to 
increased interstitial fluid content. And there is also chronic inflammatory 
cells infiltration in the retro-orbital tissue. All these lead to swelling of 
extra ocular muscle and increased retro orbital pressure leading 
exophthalmos and optic nerve compression. 
Clinical Manifestation: 
AGE  - Graves disease – 20  - 40 yrs 
   Toxic – Multi nodular goitre – Middle (or) elderly 
   Toxic Adenoma - >40 yrs. 
SEX  - All thyroid diseases are common in females  
 Clinical features are the same in Grave’s or toxic Multi nodular 
goitre except that Graves disease is associated with more severe toxicity 
& with extra thyroidal manifestations. There may be family H/O other 
autoimmune diseases. 
 In Grave’s the onset is sudden also remissions and exacerbations 
and more of neurological symptoms. In toxic Multi nodular goitre. The 
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onset is insidious and may be also with cardiac failure (or) atrical 
fibrillation and  more of CVS manifestation.  
 There is an increased caloric turnover and Hypermetabolic state. 
The most significant symptoms are loss of weight despite increased 
appetite, preference to cold and palpitation, heat intolerance and 
excessive sweating. 
Gastro intestinal symptoms: 
 Diarrhoea, Weight loss despite good appetite. 
CVS: 
- Pedal edema, Cardiomyopathy, CCF. 
- Increased Heart rate, Blood pressure,cardiac output, and Blood 
volume,  
- Widened pulse pressure (corrigan’s pulse), chest pain, 
dyspnoea, palpitation. 
Cardiac Rhythm abnormalities: 
• Sinus tachycardia 
• Multiple extrasystole 
• Paroxysmal atrial tachycardia and atrial fibrillation 
• Persistent atrial fibrillation not responding to digoxin.  
Neurological: 
• Nervousness, irritability, restlessness, excitability 
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• Emotional liability, psychosis 
• Tremor, Hyper reflexia, illsustained clonus 
Muscular system: 
• Muscle weakness, proximal myopathy 
• Periodic paralysis (only noted in Chinese) 
• Hair – Brittle and fine leading to hair loss 
• Nail – onycholysis, clubbing  
Reproductive System: 
 Amenorrhaea, oligomenorrhoea, Infertility, Spontaneous abortion, 
loss of libido and Impotence. 
Dermatological 
• Pretibial myxoedema 
• Increased Sweating, pigmentation 
• Vitiligo, thyroid Acropachy 
• Spider naevi, palmar erythema 
Other features: 
 Fatigue, apathy, gynaecomastia, osteoporosis (elderly) 
Neck Swelling: 
1. Grave’s – diffuse symmetrically enlarged goitre  
2. Toxic MNG – Multinodularity, firm nodule  
3. Toxic Adenoma – Single palpable nodule.  
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Pretibial Myxoedema: 
• Incidence 3-5% 
• Nearly always associated with true exophthalmos and high levels 
of TRAb. 
Infiltrative dermopathy: 
• Mucin like deposit in the skin causing skin thickening. 
• Symmetrically in early stage characterized by shiny red plaque of 
thickened skin with coarse hair and may be cyanotic when cold. 
• In severe cases skin of whole leg, foot and ankles are involved, 
associated with clubbing of fingers and toe (Thyroid acropachy). 
• Rarely requires treatment local injection of Triamcinolone or Beta 
methasone ointment under occlusion dressing may be effective. 
Ocular Manifestation: 
 Some degrees of exophthalmos is common in all the cases. True 
exophthalmos is proptosis of eyes caused by infiltration of retrobulbar 
tissues with fluid, round cells and spasm of upper eyelid. Levator 
palpebrae superioris is partly innervated by sympathetic and its 
overactivity causes lid retraction and lid lag. 
American Thyroid association classification of eye signs in Graves 
disease. 
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N - 0 - No sign or Symptoms 
 O - 1 - Only sign 
 S - 2 - Sign and symptom 
 P - 3 - Proptosis 
 E - 4 - Extra ocular muscle involvement 
 C - 5 - Corneal involvement 
 S - 6 - Sight loss (Optic Nerve damage) 
Eye Signs: 
I. Lid  lag and Lid retraction 
II. Signs of Exophthalmos: 
 Von – Grafe’s Sign- Lid lag 
 Dalrympte’s Sign - Lid retraction and upper sclera is visible 
 Joffroy’s Sign - Absence of forehead wrinkling when Patient  
       looks up. 
 Stellwag’s Sign - Infrequent blinking staring look. Widened  
  palpebra. 
 Moebius Sign - Absence of eye ball convergence due to  
muscle weakness. 
III. Opthalmoplegia 
 Most common involved muscle is elevators of eye – Inferior 
oblique and Superior Rectus  Diplopia commonly occurs at upward and 
outward gaze. 
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IV. Chemosis: 
 Conjunctiva is edematous, congested, edema of eyelids, 
conjunctival infection and chemosis are aggravated by compression of 
ophthalmic vein causing increased lacrimation and  photophobia. 
Malignant Exophthalmos: 
 If the above mentioned features are severe and progressive it is 
termed Malignant exophthalmos. Papilledema,  corneal ulceration and 
optic nerve damage & vision loss occurs. 
Examination of Exophthalmos: 
Naffzieger’s method-patient in sitting posture with extended neck, 
when observed from behind, protruded eyeball can be visualized. 
Exophthalmometer (Hertel):  
 Measures the distance between lateral bony orbital margin to 
anterior  surface of cornea. 
Comparison: 
Features Primary Secondary 
Age 20 – 40 Middle (or) Elderly 
Pre-existing goitre Not prominent Long standing goitre 
Goitre Diffuse, smooth Nodular 
Exophthalmos More common Less 
Extra thyroid  
Manifestations  
Yes No 
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Neurological 
Manifestations 
More pronounced Less 
Cardiovascular 
Manifestations 
Less More pronounced 
 
Unusual causes of Hyperthyroidism 
Thyrotoxicosis Factitia: 
 Hyperthyroidism due to excessive intake of thyroxin. It occurs only 
if the dose exceeds the daily requirement. Doses below the daily 
requirement only suppress the normal Thyroid function test. 
Radio active Iodine uptake – is low 
Treatment -     To stop the drug and treat with  carbimazole and   
propranolol.  
Jod Basedow’s disease: 
 (Jod German word for iodine) 
 Diffuse toxic goitre called Basedow’s disease. Large doses of 
iodine given to hyperplastic endemic goitre which causes temporary 
Hyperthyroidism. 
De Quervain’s thyroiditis  (Auto immune thyroiditis): 
During the early stage there is Hyperthyroidism due to leakage of 
hormones from the gland. 
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Functioning Metastatic thyroid carcinoma rarely cause 
Hyperthyroidism. 
Neonatal thyrotoxicosis: 
 Babies born to hyper thyroid mother have high titres of TSH and 
TRAb. Since both TSH and TRAb will cross the placenta. It gradually 
subsides in about 3 wks time and Ab titre gradually comes down.  
Post – Partum thyroiditis 
 Causes Hyperthyroidism in early stage. 
T3 thyrotoxicosis: 
 T4 level is normal and T3 level  alone is increased and RAIU – 
Normal. This condition commonly occurs in endemic goitre with solitary 
nodule. 
Investigations 
Assessment of thyroid function: 
TSH – N 0.15 – 4.2 µu/ml 
It is done by immuno assay using monoclonal antibodies. 
 TSH ↓ -  Hyperthyroidism 
 TSH  ↑ -  Hypothyroidism 
 If TSH is altered, T3, T4 has to be measured. Many consider that 
TSH is the most sensitive method to assay thyroid function. 
TotalT4 and FreeT4: 
 TT4 - N 55 – 150 n mol/L 
 FT4 - N 12 – 28 p mol / L 
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Free T4 is increased in early Hyperthyroidism in which the Total T4 
is normal. 
Total T3 and Free T3 
 TT3 - 1.5 - 3.5 n mol/L 
 FT3 - 3 – 9 p mol/L 
Free T3 is increased in early Hyperthyroidism where Total T3 is normal. 
T4 is bound to globulin, albumin & other carrier proteins.  
 Pregnancy, oestrogen intake and oral contraceptive pills intake all 
increased carrier protein level. increased in TBG level →↑Total T4 and 
Total T3 level leading to false +ve results, but Free T3 and Free T4 
remains the same. So in those persons it is ideal to measure free hormone 
level. 
 In some centres, total hormone assay has been obsolete and only 
free hormone assay is done. But in some places it is still being done low 
T3 syndrome occurs in starvation and propranolol intake. 
Antibody assay: 
 Anti microsomal Ab and Antithyroglobulin Ab are increased in 
70% of Hyperthyroidism. TRAb is detected in 90% of Graves disease. 
Thyroid scan – Isotope scan (Radio active Iodine uptake study): 
• Thyroid scan is carried with either Radio active I 123 or Tc 99m. 
• I 131 is used for Radio – ablation of Thyroid, Usually after 24hrs the 
gland takes up 16-48% of isotope is detected. 
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• But when the uptake is >48% → Hyperthyroidism. 
• USG (or) Isotope study – is useful in grave’s Disease Routine 
Isotope scan is inappropriate to differentiate between benign and 
malignancy. 
• Its principle value is in toxicity due to toxic multinodular goitre or 
toxic nodule. Localization of over activity of the gland will 
differentiate between the toxic adenoma and Toxic MNG. 
 Grave’s   -  Diffuse,   increase in uptake 
Toxic Multi nodular goitre -  Internodular tissue is overactive  
      remaining gland is inactive. 
Toxic adenoma  -  Nodule is overactive remaining  
gland is suppressed.  
According to uptake: 
Warm Uptake similar to adjacent thyroid tissue 
Hot Over active nodule than surrounding thyroid 
Cold Non – functional / Hypofunctional 
 
Sl.No. RAIU ↑ed uptake Sl.No. RAIU ↓ed uptake 
1. Grave’s 1. Thyroiditis – early phase 
2. Toxic adenoma 2. Iodine induced – Jod Base dow’s 
Thyroiditis 
3. Toxic MNG 3. Hashimoto’s thyroiditis 
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USG Thyroid: 
 High frequency USG delineates the cyst and nodules and detects 
unpalpable nodules. 
 Any thyroid nodule has to be subjected to FNAC and cysts can be 
diagnosed when aspiration is attempted as part of investigating a nodule 
on FNAC and so USG is not absolutely necessary to diagnose cyst of 
thyroid. The value of USG is decreasing nowadays.  
FNAC 
 Not usually required for toxic thyroid unless there is palpable 
nodule and in which carcinoma cannot be ruled out. 
 Done with 23 – 24 Gauze needle & 10-20ml syringe. In a single 
prick, multiple passes are made inside the thyroid tissue. 
 Some slides are alcohol (70%) dried & the some are air dried & 
papanicolaue  stained. FNAC is highly sensitive to rule out malignancy. 
X-ray neck Anteroposterior and Lateral 
 Will show Anteroposterior compression of trachea, lateral 
deviation of trachea, calcification of thyroid, shadow of thyroid gland and 
Retro – Sternal goitre. 
CT – Scan  and MRI Scan 
 Shows Retro sternal extension 
X-ray chest – PA view 
 Assess cardio – pulmonary status, retro-sternal extension. 
 Lung metastases in malignancy 
28 
 
ECG, ECHO 
 Cardiac status, and any arrhythmias can be found out. 
Indirect laryngoscopy: 
 Vocal cord status, pre operatively for clinical and Medico – Legal 
purpose. 
Serum Protein – Bound Iodine(PBI): 
 It is cheap and can be easily assessed but lacks specificity as it 
measures the non-hormonal forms of iodine in the blood. In euthyroid 
state range is 3.5 – 8  µg/100ml. 
False positive -  Pregnancy, person taking iodides in  various  
forms particularly contrast media, expectorants  
containing iodides and oral contraceptives.  
False negative - Salicylates, androgens, hydantoin  like drugs 
and nephrotic syndrome. 
Free thyroxin index: 
FT index = Serum T4 (or) PBI x T3 uptake percent. Normal = 3.5- 8 
This correlates closely with level of FreeT4 in serum and thus 
accurately reflects the thyroid status of the person. 
T3 Resin uptake: 
The patient serum is incubated with Radio activeT3. So that latter 
becomes fixed to any thyroid binding protein not carrying the hormone. 
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The amount fixed can be measured & thus the number of binding 
sites in the serum that are unoccupied can be measured. 
• Naturally in hyperthyroidism, the number of free binding sites is 
low and in Hyporthyroidism this number is high. The secondary 
binder, where the unutilized Radio acitive T3 become fixed can be 
resin or thyopac. 
• The fraction of labelled T3 taken up by the resin can be compared 
with that of a standard serum and this test is called as “Resin 
uptake ratio.” 
• Normal = 0.91 – 1.21 µg. 
• While using thyopac method one may take 100% as the mean 
normal value for free binding sites. In this case less than 85% will 
suggest Hyperthyroidism as in this case the number of free sites 
will be less. 
• A figure of 120% suggest Hypothyroidism as the number of free 
sites is high. 
TSH stimulation test: 
Measures the response of pituitary to I.V. administered 
Thyrotropin releasing hormone, the Hypothalamic stimulator of TSH, 
TRH given in dose of  400µgm (or) 1.73µgm/sqm. 
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• In euthyroid person with normal pituitary function, a prompt 
increase in TSH level which occurs and it peaks at 20-30mts. 
• In Hypothyroidism, Basal TSH ↑ - Following TRH administration 
the reaction is more and TSH often reaches 100-200µ/L at 30mts. 
• In thyrotoxicosis TSH response absent,when TRH is administered.   
Test for Hypothalamo – Pituitary Thyroid axis: 
 When TRH is given, I.V in a dose of 200µg to a normal person, the 
level of TSH increase from basal level. From1µu/ml to a mean peak of 
10µu/ml at 20 mts and returns to normal in 120 mts. 
• In Hypothyroidism – there is an exaggerated rise of an already 
elevated TSH. 
• But in Hyperthyroidism – there is response of a depressed level. 
T3 Suppression test (Werner): 
 This is used to differentiate thyrotoxicosis from other causes of 
raised uptake (eg) Iodine deficiency and autonomous nodules. 
Serum thyroglobulin level:  
Increased in thyroditis, Grave’s disease, toxic multinodular goitre 
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MANAGEMENT 
1. Antithyroid drugs 
2. Surgery 
3. Radio active Iodine ablation 
Drugs: 
I. Drugs that inhibit  hormone synthesis by blocking peroxidase enzyme      
• Propylthiouracil 
• Carbimazole 
• Methimazole 
II. Drugs that inhibit iodine trapping 
• Thiocyanates 
• Perchlorates 
• Nitrates 
III. Drugs that inhibit hormone release 
• Iodides of sodium, K+ iodine 
IV. β- Blockers 
• Propranolol 
• Nadolol 
Propylthiouracil & Carbimazole 
 Inhibit Peroxidase   → inhibit iodination and coupling 
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 Hormone synthesis is affected, also inhibits the peripheral 
conversion of T4 → T3. 
 Carbimazole converted to its active metabolite methimazole. 
 In USA propylthiouracil and  Methimazole are commonly used.  
In UK–  only Carbimazole is used. 
 All these drugs have no effect on underlying disease process. 
 Drug      Dose / day 
1. Propylthiouracil    100 – 300mg tds 
2. Methimazole    10 – 30 mg tds 
3. Carbimazole    5-15 mg tds 
4. Propranotol     40 – 60 mg tds 
 Initial response is attained in 2 weeks. After attaining response the 
dose is reduced to maintainance dose. 
Blocking replacement regimen: 
 Usually after giving the initial high dose, the drug is reduced to 
maintainance dose. But in this regimen, Initial high dose is continued and 
Thyroxin is supplemented. This is called Blocking and replacement 
regimen.  
Side effects: 
a) Skin rashes, pyrexia, peripheral neuritis, vasculitis, arthritis, 
hepatitis. 
b) Sorethroat, fever 
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c) Granulocytopenia – reversible, if drug is discontinued 
d) Agranulocytosis – Incidence 1 in  250 
e) Aplastic anemia – rare 
When agranulocytosis occurs, it can treated with rh – G – Colony 
Stimulating factor. If side effects occurs for one drug, the therapy can be 
switched on to another drug as there is no crossreaction between the 
drugs. 
Advantages: 
• No surgery 
• No Radiation 
Disadvantages 
• 50% relapse rate 
• Toxicity and Drug side effects 
• Teratogenicity all antithyroid drugs except propylthiouracil 
cross the placenta and secreted in milk. 
• Longterm follow – up is necessary 
• Poor patient compliance unsuitable for illiterate people. 
β-Blockers 
Propranolol: 
• No action on gland. 
• Inhibits peripheral conversion of T4 → T3 
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• Inhibits sympathetic activity and results in alleviation of 
sympathetic mediated symptoms like tremor, excitability and 
nervousness. 
• There is improvement of toxicity and rapid symptomatic improval. 
It can be used for Rapid correction to euthyroid state before 
surgery. Dose 40mg 8th hrly. 
Nadolol: 
• Long acting β- Blocker 
• Single daily dose of 160mg/day 
Iodides: 
• Inhibit hormone release 
• Lugol’s Iodine (5% Iodine in 10% KI solution) reduces vascularity 
and also makes the gland firmer and easier to handle and less 
bleeding during surgery. Usually given 10 days before surgery in a 
dose of 5 drops 8th hrly mixed with milk or water. Alternatively 
Pottasium Iodide tablets can be given at 60mg tds / day. 
Anti-thyroid drugs used in 3 main ways: 
a) As a definitive form of treatment 
b) In pre-op preparation for surgery 
c) In association with Radio iodine ablation. 
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Drug therapy: 
Unsuitable for the following 
• Large diffuse gland 
• Toxic Multi nodular goitre 
 On discontinuing the drug after attaining response it results in high 
rate of recurrence and definite treatment in the form of surgery or Radio 
iodine ablation is indicated in above mentioned condition. 
Radio Iodine Ablation therapy: 
• I131 is the most commonly used drug 
• Therapeutic dose higher than the tracer dose 
• First used by Hertz and Roberts 
Affinity of Hyperplastic thyroid gland to iodine forms the basis for 
treatment RI131 is given as oral drink, which disintegrate within gland and 
emits β -rays. Penetrate the other tissue for few mm only and so the RLN, 
parathyroid and cartilage are not affected. The γ  radiation is too small to 
cause to any damage. 
Procedure: 
 500 – 750 MBq (or) 10 mci (or) 8500 CGY. 
• All patients should be made euthyroid before therapy with 
Antithyroid drugs. 
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• Stop the Anti thyroid drugs, about 2-3 weeks, before therapy 
to allow iodine uptake of thyroid. Radio active idoine given 
in the form of oral drink I131. 
• After the single dose of therapy the response rate is 75%. 
• Response is slow and occurs usually in 8-12 weeks time. 
• If necessary and if the response does not occur within 12hrs, 
the therapy can be repeated. 
• Higher the initial dose given, higher is the Hypothyroidism. 
• Response occur after a period of 4-12 weeks, and during this 
lag period. Anti thyroid drug is given. Before ablation, an 
isotope scan is done to assess the size of gland. 
Suitable for: 
• Small or moderate sized 
• Relapse after drug or surgery 
• In whom surgery or drugs contraindicated 
• Older Patients treated with Radio active idoine Ablation. 
Contra indication 
Absolute - Pregnancy and Lactation 
Relative - Ophthalmopathy 
- Isolated thyroid nodule or Toxic MNG 
- Young age – Children and adolescence 
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Disadvantages: 
• increased incidence of leukaemia, thyroid malignancy and other 
malignancies. 
• Long term follow up is essential 
• Repeated doses may be required. 
Complication 
• Exacerbation of thyrotoxicosis, arrhythmias, CCF 
• Thyroid storm 
• Hypothyroidism 
• Hyper parathyroidism 
• Worsening of eye signs 
• Fetal damage in pregnancy 
SURGERY 
Subtotal thyroidectomy: 
• Leaving behind 1/8 of normal gland 
• 5 cubic cm of gland is left or 4-5gm of tissue is left 
• Small portion of gland left on either side of trachea  
Near total thyroidectomy: 
 Remove one lobe completely and leave <2gm on other side. 
(Hartley Dunhill procedure), so that the chance of damage of RLN is 
reduced in subsequent surgery if there is any recurrence. 
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Pre op preparation: 
• Carbimazole 
• Propranolol 
• Lugol’s iodine 
Recurrence Treatment 
• Large diffuse glands and young patient → surgery  
• Small, moderate size → RI ablation 
Subtotal Thyroidectomy: 
• 10% recurrence rate 
• 70% developed Hypothyroidism on 10 yrs follow up 
• So current consensus is to do total or Near total thyroidectomy and 
put them on Thyroxin. 
Toxic Multi nodular goitre: 
• Anti thyroid drugs or RI therapy is less effective 
• Surgery is the treatment of choice 
• And in this too the original standard treatment is subtotal. But now 
the current trend is total thyroidectomy and Thyroxin replacement. 
Toxic adenoma: 
 Total lobectomy – Treatment of choice 
 RI ablation can be given in elderly and unfit patients. 
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Recurrent thyrotoxicosis: 
 Radio active idoine ablation therapy is the treatment of choice. 
Thyrotoxicosis in Children: 
 Radio active idoine therapy is contraindicated following surgery, as 
there is increased recurrence as the follicular cells are active. So treat 
them with drugs until late teenage and in failure of surgery can be done. 
Treatment of Exophthalmos: 
• Sleeping propped up 
• Wearing glasses during day 
• Cover the eyes during the night 
• Artificial tears to protect 
• Guanethidine eyedrops & steroid eyedrops 
• Massive doses of steroids (Prednisolone 60mg/day) 
↓ 
  Chemosis 
• Orbital decompression (or) retro orbital radiation may be required 
to save the eye when it is in danger. 
• Retro – orbital radiation by super voltage X-rays.  
Total thyroidectomy should be undertaken only in patients with 
severe exophthalmos, when well prepared.  
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Comparision study of  3 Treatment Modalities 
Sl.No. Criteria Antithyroid drugs Surgery RI Ablation 
1. Mortality Nil <1 % Nil 
2. Speed of control 8 – 12 wk Immediate - 
3. Response rate 50% 85 – 95% 75% 
4. Goitre Remains the same (or) 
regress 
Removed Destroyed 
5. Hypothyroidism Occasional but 
temporary 
10% after 1yr 
30% later 
70% after 10yr 
50% after 
10yrs 
6. Occular disease Improved Improvement 
after total 
thyroidectomy 
If severe 
exophthalmos
        ↓  
Exacerbation 
rate more. 
7. In patient Treatment Not usually necessary 
unless severe 
Essential Before 
surgery 
Essential 
8. Discomfort Nil Yes Yes 
9. Tetany  Nil Transient – 3% 
Permanent 1-2% 
Less 
10. Vocal cord palsy Nil Present Nil 
11. Drug reaction Yes Less as the drugs 
are discontinued 
before surgery 
Less as the 
drugs are 
discontinued. 
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SUBTOTAL THYROIDECTOMY 
PROCEDURE 
Position : 
 Under General anaesthesia patient is put in supine position with 
neck hyperextended by placing a sand bag under shoulder  
Incision : 
 Horizontal low - collar incision is put 2 finger breadth above the 
sternal notch extending from sternomastoid of one side to the other lateral 
borders.  
Steps : 
1. The skin and platysma are incised 
2. Upperflap raised upto thyroid cartilage, lower flap raised upto 
sterno clavicular joint.  Deep fascia is opened vertically in the 
midline.  
3. Strap muscles are retracted or cut in between two artery forceps.  
4. Pretracheal fascia is opened to mobilize the thyroid 
5. Middle thyroid vein is ligated  
6. Superior thyroid pedicle is ligated close to the gland so as to avoid 
injury to external laryngeal nerve 
7. Inferior thyroid artery is ligated away from the gland so as to avoid 
injury to recurrent laryngeal nerve.  
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8. The gland is mobilised meticulously from the thyroid bed and 
leaving behind fringe of tissue over the tracheo oesophageal groove 
to avoid recurrent laryngeal nerve injury and preserve parathyroids. 
9.  After complete haemostasis, wound is closed in layers with drain 
insitu. 
Complications : 
1.  Haemorrhage 
 May be due to slipping of ligature.  It causes tachycardia, 
Hypotension, breathlessness and compression over the trachea which 
inturn cause severe stridor, respiratory obstruction.  As a first aid 
immediate release of sutures including that of deep fascia has to be done  
in the ward itself and pressure over the trachea was released.  Then shift 
the patient to Operation theatre and explore under GA and bleeding poins 
are identified and ligated.  
2.  Respiratory obstruction : 
 Due to Haematoma or laryngeal edema  
For Haematoma – needs to be evacuated immediately  
For laryngeal edema – immediate emergency  endotracheal intubations is 
done along with administration of steroid injection – Often emergency   
tracheostomy may be required as a life saving procedure.  
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3.  Recurrent laryngeal nerve palsy.  
 If can be transient (or) permanent.  Transient is 3% common.  They 
usually recover in 3 Wks to 3 months.  Often they require treatment with 
steroid and speech therapy.  Permanent paralysis is rare.  
4.  Hypoparathyroidism (0.5%) 
 Caused due to sapsm of arteries of parathyroid glands, occurs in 2nd 
to 5th day. Patient will present with weakness, positive chvostek’s sign, 
carpopedal spasm and convulsions.  Serum calcium estimation is done 
and then 10ml of 10% calcium gluconate is given IV 8th hrly.  Later 
supplemented by oral calcium 500 mg 8th hrly.  After 3-6weeks later 
patient is admitted, drug is stopped and serum calcium level is repeated.  
5.  Thyrotoxic crisis (Thyroid storm) 
 Occurs in a patient inadequately prepared for thyroidectomy.They 
present peroperatively or within in 12-24 hrs with severe dehydration, 
circulatory collapse hypotension, hyperpyrexia and often cardiac failure.  
Treatment: 
 Inj Hydrocortisone, oral antithyroid drugs.  Tepid sponging of 
whole body, Antipyretics, Intra venous β- Blocker injection, oral iodides, 
large amount of IV fluids, digitoxin cardiac monitor ventilator support.  
 It has got high rate of mortality with critical period of 72 hrs.  
6.  Injury to external laryngeal nerve causes weakness of cricothyroid 
muscle leading to alteration in pitch of voice  
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7.  Hypothyroidism  
8.  Wound infection, Stitch granuloma 
9.  Keloid formation.   
10. Injury to trachea and oesophagus. 
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MATERIALS AND METHODS 
 This is a prospective study of randomly selected patients who 
presented with hyperthyroid symptoms, of toxic goitre who were 
diagnosed and treated at Dept of General surgery TVMCH during the 
period of June 2007 to November 2009. 
 Each patient’s symptoms and signs were entered in proforma with 
detailed clinical examination in relation to thyroid.  All the patients were 
subjected to basic investigations like Complete haemogram, Blood – 
Urea, sugar, creatinine, chest x-ray.  Thyroid profile, x-ray neck and 
ECG. were taken for the cases.  Radio-Isotope study was not done since 
facilities are not available in our hospital.  
 Since RI ablation therapy is not available in our hospital, our 
patients were treated with either Antithyroid drugs or surgery. 
 Surgery was the modality of treatment offered to all the patients.  
 Out of 50 cases surgery was done for only 45 cases and for 
remaining 5 Cases surgery was deferred due to various reasons and these 
patients were treated with Antithyroid drugs only.  
 The 45 Patients who were planned for surgery were put on 
antithyroid drugs as part of pre-op preparations to euthyroid state and to 
prevent thyrotoxic   crisis.  They were monitored by daily sleeping pulse 
chart, periodic weight monitoring and by symptomatic improval.  Surgery 
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was done after bringing the patient to euthyroid state pre operatively with 
antithyroid drugs.   
Pre-Operative preparation : 
 Most of our patients required an average dose of carbimazole 10mg 
8th hrly, propranolol was also given in a dose of 40mg 12th hrly. For 
patients with severe toxic symptoms 10days prior to surgery, Lugol’s 
iodine 5-10 drops 8th hrly was given to patients.  Few Pts were given 
colloidal iodine instead of Lugol’s iodine.  Night sedation was given with 
diazepam or alprazolam. One patient’s toxic symptoms reduced only with 
propylthiouracil 100mg tds. 
 Surgery in the form of subtotal or near total or total thyroidectomy 
was done.All operated specimen was sent for Histopathological 
Examination and analysed. 
 Post op complications were analysed and the patients were 
regularly followed up.  
 The Patients in whom surgery was deferred were treated with 
Antithyroid drugs.  Total T4 level 3 months after surgery (for 45 patients) 
and total T4 level after 3 months after medical therapy (for 5 patients) 
were measured and analysed 
 All the observation were analysed and compared with results.  
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Age incidence : 
 
S.No Age Group No of patients Percentage 
1 16-30 14 28% 
2 31-45  28 56% 
3 46-60 8 16% 
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Sex incidence  
 
S.No Sex No of patients Percentage 
1 Male 5 10% 
2 Female 45 90% 
 
 
Familial Incidence  
 In this study no familial incidence was noted.  
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Clinical presentation : 
 
S.No Type of goitre No.of Patients Percentage
1 Primary - Diffuse toxic goitre 15 30% 
2 Secondary - Toxic MNG  35 70% 
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S.No Clinical feature No.of Patients Percentage 
1 Goitre All 100% 
2 Tremor 19 38% 
3 Palpitation 35 70% 
4 Heat intolerance 21 42% 
5 Excitability 20 40% 
6 Sleep disturbances 30 60% 
7 Weight loss 32 64% 
8 Diarrhoea 32 64% 
9 Muscle weakness 19 38% 
10 Menstrual Abnormalities 3 6% 
11 Ophthalmopathy 11 22% 
12 Bruit  5 10% 
 
  
Few patients had menstrual abnormalities like oligomenorrhcea 
which got corrected once the patients were brought to Euthyroid state.  
None of the patients included in study had chest pain, dyspnoea, other 
cardiac symptoms and pressure symptoms like dysphagia, hoarseness of 
voice.  
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Grade of toxicity  
S.No Grade Range No.of Patients Percentage 
1 I0 <90 4 8% 
2 II0 90-110 16 32% 
3 IIIo >110   30 60% 
 
Treatment and follow up  
 In our series surgery was done for 45 patients.  In the rest of 5 
patients surgery was deferred for the following reasons.  
 1 patients was not not willing for surgery  
 2 patients were anaesthetically unfit for surgery  
 2 patients were referred to Higher centre for Radio ablation  
therapy. 
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They are treated with Antithyroid drugs.  
All the patients who were planned for surgery were put on 
antithyroid drugs as previously stated to attain euthyroid status before 
surgery.  
Control of toxicity after pre op preparation  
 Duration for control of toxicity is analysed.  Some patients with 
mild toxicity and early cases become euthyroid in 2 weeks and in other it 
ranged from 3-6 wks to control the toxicity.  For few patients it took 
around 8 weeks for controlling toxicity.  
Histo Pathological Examinations: 
Two patients has show evidence of malignancy 
• Hurthle cell carcinoma 
• Papillary carcinoma thyroid 
Surgical Treatment : 
 Surgery subtotal, near total, and Total thyroidectomy was done.  
T4 level measured in all cases 3 months after surgery.  
Subtotal - 33 
Near Total - 8 
Total  -4 
Control of toxicity with drugs.  
In 5 patients in whom surgery was deferred antithyroid therapy was 
started.  They were given T. Carbimazole 10-20mg 8th hrly, T. 
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propranolol 40mg 12th hrly.  T. Diazepam for night  sedation. T4 level 
was measured in all the cases 3 months after therapy.  
Complications 
 During Surgery and in post Op period the complications were 
encountered and are summarized, 
2 patients have developed Hypoparathyroidism which manifested as  
 Tetany 
 Carpo-pedal spasm 
 Positive Chvostek’s sign 
 Positive Trousseau’s sign  
One  Patient developed symptoms on 2nd day,  and other on 3rd day.  
They were managed as follows  
 Serum calcium estimation  
 Serum phosphorus 
Treatment:  
• Oral calcium 
• IV calcium gluconate 
Two  Patients had unilateral Recurrent Laryngeal nerve palsy, It 
manifested as  
• Hoarseness of voice 
• Coughing while taking liquid drinks. 
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• Subsequent IDL scopy showed the paralyzed vocal cord in para 
median position. 
• They did not develop aspiration 
• They were treated with I.V. Steroids, (Dexamethasone and 
Hydrocortisone) 
• They improved symptomatically subsequently  
• They were reassured and did not develop any further complication.  
One Patient developed stitch granuloma It presented as  
 Continuous serous discharge from a sinus in the scar for about 3 
months in post operative period.  
Wound was explored under local anaesthesia and there was found 
to be silk suture protruding in the sinus.  
The sinus was cut as low as possible and the scar was excised and 
wound resutured. 
Inference – use of non-absorbable suture material causes stitch 
granuloma and sinus.  
• One Patient developed subcutaneous Haematoma and was treated 
by aspiration.  
• Two Patients developed tension Haematoma.  They were 
immediately explored and haematoma evacuated.  Bleeding sites 
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identified and ligated. Perfect Haemostasis obtained.  Wound 
closed.  
There was no incidence of thyroid storm or Respiratory distress or 
Recurrent thyrotoxicois.  All the patients are living  normally without any 
symptoms.  
Complication Rate : 
Sl.No 
Ranges of results of 
surgery 
From Hershmant 
ranges of % 
In our series 
1 Mortality  <3.1% Nil 
2 Vocalcord palsy 0.0 – 4.4% 4% 
3 Hypoparathyroidism  0.0-3.6% 4% 
4 Recurrent thyrotoxicosis  0.6-17.9% Nil 
5 Hypothyroidism  4-29.7% 20% 
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STATISTICAL ANALYSIS 
 The T4 level is measured in all the cases before therapy and 3 
months after therapy and the results were analysed.  
 Normal value of T4 =55-150 nmol/L 
 The mean T4 level before therapy  
 Before surgery in 45 cases  
  21.68 ± 2.42 I.S.D. 
Before Antithyroid treatment in 5 cases  
 20.3 ±3.66 I.S.D. 
The mean T4 level after therapy  
 After surgery in 45 cases  
 4.03 ± 2.15 I.S.D. 
After Antithyroid treatment  
 14.46 ±1.28 I.S.D.  
Mean decrease of T4 in cases treated with Antithyroid durgs is 
 5.84 ± 2.81 I.S.D.  
 The significance of difference in mean of T4 level between patients 
treated medically and surgically.  
 P = 0.0003 
 This indicates the values are insignificant  
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DISCUSSION  
• Most of the patients who were diagnosed to have thyrotoxicosis 
were in the age group 31-45 years.  Most of the patients who 
presented with graves disease were in the age group of 15-30 years.  
Most of the cases with toxic Multi nodular goitre were in the age 
group of 31-45 years.  
• In our study the incidence of thyrotoxicosis in females was high 
and the male : female ratio in our study was 1:9. 
• There were no familial incidence in our study.  
• Most of the patients had toxic Multi nodular goitre 35 patients and 
none of our cases included in study had solitary toxic nodule. 
• All the patients had goitre.  The most significant clinical features 
were palpitation, weight loss, diarrhoea, sleep disturbances, 
excitability and heat intolerance in the order of frequency.  
• With regard to pulse rate, 60% cases had severe toxicity 3rd degree 
with pulse rate of >110/mt.  
• TSH, Total T4, Total T3 level estimation was done for all cases.  In 
all cases, the TSH was reduced, T4 and T3 was raised confirming 
the Hyperthyroid state and indicating the severity of disease. T4 
estimation repeated for all cases 3 months after therapy (both 
surgery and drugs). 
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• All the patients in whom surgery was planned were given 
antithyroid drugs and takenup for surgery after adequate control of 
toxicity.  This prevented the complication of thyroid storm in the 
per operative and in post operative period.  
• After giving Antithyroid medication, euthyroid state was attained 
after average of 3-4 weeks with a minimum of 2 weeks and 
maximum of 8 weeks. 
• Most of cases underwent subtotal thyroidectomy.  All the cases 
were followed up in post operative period until the study period.   
• It was noted that none of our patients had recurrent thyrotoxicosis   
and there was no mortality with a little morbidity.   
• The patients who underwent total thyroidectomy  were given 
thyroxin replacement in the form of Eltroxin tablets in a dose of 0.1 
mg /day.   
• The Histopathology of operated specimen was studied and there 
was evidence of malignancy in HPE of operated specimen of two 
patients. 
• The mean T4 level for patients treated with surgery and Antithyroid 
drugs was analysed 3months after therapy.  The T4 level in the 
patients treated with surgery has decreased significantly to normal 
level (or) to just below normal level. 
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• But in cases treated with Antithyroid drugs the T4 level decreased 
to an average level of 12-14ηu/ml which is just above the normal 
level.  
• Out of 5 patients treated with Antithyroid drugs.  Only one case 
came for routine follow up and other 4 patient did not turn up after 
3 months.  And the significance of drug therapy in them could not 
be assessed properly.  
• From the available data in general it can be stated that surgery is 
the appropriate form of treatment that can be safely offered to 
patients with thyrotoxicosis in our setup.  Since patients do not 
come for routine and regular follow up.  
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CONCLUSION  
 In this study, a comprehensive account of History, anatomy, 
physiology, with a detailed account of clinico-pathological aspects, 
presentations and various modalities of treatment of thyrotoxicosis have 
been dealt with 50 cases of thyrotoxicosis . 
 From the evidence it is clear that after adequate control of toxicity 
with anit-thyroid drugs, surgery is the modality of treatment that can be 
safely offered to patients with thyrotoxicosis in our hospital.  
 This present study confirms the observation made by the reputed 
authors and emphasize the importance of perfect and sufficient pre 
operative preparation, meticulous surgical technique, detailed knowledge 
about anatomy of thyroid, parathyroid and associated  nerves to assure 
complete remission with negligible morbidity and nil mortality.  
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PROFORMA 
NAME :      Occupation : 
AGE/SEX :      ADDRESS 
IP.NO : 
D.O.A :   D.O.S  D.O.D 
Complaints 
H/o PRESENT ILLNESS 
Symptoms : 
Swelling : Mode of onset 
   Rate of growth 
Pain 
↑ ed appetite & Weight loss 
Heat intolerance & Preference to cold 
Excessive Sweating 
Excitability, irritability, restlessness 
Insomnia 
Tremor of hands 
Palpitation 
Muscle weakness 
Visual disturbance 
Diplopia 
Protrusion of eyes 
Chest pain 
Dyspnoea 
Dysphagia, hoarseness of voice 
H/O PAST ILLNESS 
HT,TB,DM 
PERSONAL H/O 
Smoking, alcohol, intake of brassica vegetables 
FAMILY H/O 
MENSTRUAL H/O 
OBSTETRIC H/O 
TREATMENT H/O   Drug intake 
      Irradiation 
      Surgeries 
G/E 
Built 
Nutrition 
Anaemia 
Dyspnoea 
Jaundice 
Cyanosis 
Generalized lymphadenopathy 
Tremor of hands & tongue 
Leg edema (pretibial myxedema) 
EYE SIGN – Lid retraction: 
      Lid lag 
Exophalmos -    von-grafe’s sign 
      Joffroy’s sign 
      Stellwag’s sign 
      Moebius sign 
      Dalrnpte’s sign 
      Chemosis 
Pulse rate 
Sleeping pulse rate 
Respiratory rate 
Bp 
Temperature 
CVS 
Rs 
Abdomen 
CNS 
LOCAL EXAMINATION OF NECK 
INSPECTION 
• Swelling 
• Site 
• Size 
• Shape 
• Extent 
• Borders 
• Movement with deglutition 
• Movement with protrusion of tongue 
• Skin over the swelling 
• Surface 
• On sm muscle contraction 
• Trachea position 
PALPATION: 
• Warmth 
• Tenderness 
• Site, size, shape 
• Extent 
• Borders 
• Skin over swelling 
• Surface 
• Consistency 
• Mobility 
• Trachea position 
• Carotid pulsation 
• Kocher’s test 
• Pemberton’s sign 
PERCUSSION 
• Over manubrium 
AUSCULTATION 
• Bruit 
• Lymphnodes 
• Skeletal system, 
• Spines 
DIAGNOSIS 
INVESTIGATIONS 
• Urine R/E 
• Hb% 
• Te 
• Dc 
• ESR 
• Blood Urea 
o Sugar 
o Creatinine 
 
 
ECG 
ECHO: 
X-ray chest PA view 
X-ray neck 
THYROID FUNCTION TEST 
• TSH 
• TT3 
• TT4 
• FT3 
• FT4 
ANTIBODY 
• USG - Thyroid 
• Thyroid scan 
• IDL 
• FNAC 
TREATMENT 
MEDICAL 
DRUG DOSE DURATION TOXICITY 
1    
2    
3    
Treatment for drug toxicity 
Control of toxicity attain after ___________________________ Wks 
SURGERY 
Post of complication 
Type – treatment 
1. 
2. 
3. 
Propranolol continued in post op period for 7 days 
HPE 
Follow -up 
 
S.No Name Age/Sex IP.No Diagnosis Treatment
1 Velthai 27/F 12885 Diffuse toxic goitre Sub total thyroidectomy
2 Ponkodi 20/F 22327 Diffuse toxic goitre Sub total thyroidectomy
3 Latha 23/F 28507 Toxic MNG Sub total thyroidectomy
4 Radha 25/F 30571 Diffuse toxic goitre Sub total thyroidectomy
5 Kavitha 16/F 52856 Diffuse toxic goitre Sub total thyroidectomy
6 Yasmin 16/F 48930 Diffuse toxic goitre Total thyroidectomy
7 Chandra Vadhini 22/F 33531 Toxic MNG Sub total thyroidectomy
8 Raja Rajeswari 26/F 10677 Diffuse toxic goitre Sub total thyroidectomy
9 Michelammal 17/F 6908 Diffuse toxic goitre Near total thyroidectomy
10 Petchiammal 19/F 25021 Diffuse toxic goitre Sub total thyroidectomy
11 Vimala 27/F 29209 Toxic MNG Antithyroid drugs
12 Maheswari 23/F 18333 Diffuse toxic goitre Sub total thyroidectomy
13 Esakkiammal 22/F 37238 Toxic MNG Sub total thyroidectomy
14 Vijayakumar 29/M 21239 Toxic MNG Sub total thyroidectomy
15 Syed Ali 36/F 40325 Toxic MNG Sub total thyroidectomy
16 Muthukumari 38/F 37056 Toxic MNG Near total thyroidectomy
17 Avudaiammal 40/F 4958 Toxic MNG Antithyroid drugs
18 Bharagath Nisha 35/F 15185 Diffuse toxic goitre Total thyroidectomy
19 Lakshmi 32/F 35162 Toxic MNG Sub total thyroidectomy
20 Kannaki 34/F 36368 Toxic MNG Sub total thyroidectomy
21 Eswari 34/F 41725 Toxic MNG Sub total thyroidectomy
22 Jameel 38/F 6747 Toxic MNG Near total thyroidectomy
23 Mydeen 45/F 29394 Toxic MNG Sub total thyroidectomy
24 Varisaimeeral 40/F 10706 Diffuse toxic goitre Sub total thyroidectomy
25 Rani 37/F 33627 Toxic MNG Sub total thyroidectomy
26 Thangavel 44/M 38879 Toxic MNG Sub total thyroidectomy
27 Syed path 34/F 26380 Toxic MNG Near total thyroidectomy
28 Saraswathi 40/F 35786 Toxic MNG Sub total thyroidectomy
29 Guruvammal 34/F 39036 Toxic MNG Near total thyroidectomy
30 Elaika 43/F 43309 Toxic MNG Sub total thyroidectomy
31 Sakthivel 31/M 45623 Diffuse toxic goitre Total thyroidectomy
32 Santhanamari 34/F 46740 Diffuse toxic goitre Sub total thyroidectomy
33 Essakidurai 45/M 16145 Diffuse toxic goitre Sub total thyroidectomy
34 Vasantha kumari 44/F 17329 Diffuse toxic goitre Near total thyroidectomy
35 Ramalakshmi 33/F 29515 Diffuse toxic goitre Sub total thyroidectomy
36 Esakkiammal 35/F 39407 Toxic MNG Sub total thyroidectomy
37 Devi 31/F 4344 Toxic MNG Sub total thyroidectomy
38 Maliga 34/F 31272 Toxic MNG Antithyroid drugs
39 Manikaadan 32/M 15093 Toxic MNG Sub total thyroidectomy
40 Chinnathai 42/F 36462 Toxic MNG Sub total thyroidectomy
41 Pappa 40/F 2343 Diffuse toxic goitre Sub total thyroidectomy
42 Chandra 43/F 42707 Toxic MNG Antithyroid drugs
43 Arumugaammal 47/F 55071 Diffuse toxic goitre Total thyroidectomy
44 Pappathi 53/F 53914 Toxic MNG Antithyroid drugs
45 Kuthala Kannammal 35/F 2698 Toxic MNG Near total thyroidectomy
46 Mareeswari 52/F 5689 Toxic MNG Near total thyroidectomy
47 Parvuthi 55/F 15833 Toxic MNG Sub total thyroidectomy
48 Sumitra 55/F 15784 Toxic MNG Sub total thyroidectomy
49 Perumal 47/F 24163 Toxic MNG Sub total thyroidectomy
50 Bhagavathi 50/F 44971 Toxic MNG Sub total thyroidectomy
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